USPTO serial 79388998
GO SPATIAL
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- May 6, 2025
- Examiner
- MEIER, SHARON A
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with GO SPATIAL?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
BGI SHENZHEN GROUP HOLDINGS CO., LIMITED
CN
Other trademarks owned by BGI SHENZHEN GROUP HOLDINGS CO., LIMITED
CN
BGI SHENZHEN GROUP HOLDINGS CO., LIMITED
CN
Other trademarks owned by BGI SHENZHEN GROUP HOLDINGS CO., LIMITED
BGI SHENZHEN GROUP HOLDINGS CO., LIMITED
CN
Other trademarks owned by BGI SHENZHEN GROUP HOLDINGS CO., LIMITED
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Charles Ho
Charles Ho Barron & Young PLLC5465 Legacy Drive, Suite 650No. 2008 Shennan Middle Road,Plano, TX 75024Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Diagnostic reagents and preparations, except for medical or veterinary use; chemical substances for analyses in laboratories, other than for medical or veterinary purposes; biological preparations for use in cell cultures, other than for medical or veterinary purposes; biochemical preparations for scientific purposes; biological preparations, other than for medical or veterinary purposes, namely, biological preparations for use in industry and science; test paper, chemical; chemical preparations for scientific purposes, other than for medical or veterinary use; biological tissue cultures, other than for medical or veterinary purposes; chemical reagents, other than for medical or veterinary purposes; chemical preparations for analyses in laboratories, other than for medical or veterinary purposes | ACTIVE | — |
| 005 | Medical diagnostic reagents for the analysis of immune system; diagnostic preparations for medical purposes; diagnostic biomarker reagents for medical purposes; preparations for detecting mutation in prion genes for medical purposes; preparations for detecting genetic predispositions for medical purposes; reagent paper for medical purposes; reagents for use in medical genetic testing; biological preparations for medical purposes for the treatment of cancer and genetic diseases; chemical preparations being reagents for medical purposes; enzyme preparations for medical purposes | ACTIVE | — |
| 009 | Data processing apparatus; recorded computer software for managing laboratory information, data, instruments and workflows in the field of genome sequencing; downloadable computer software for database management; recorded computer software for database management; laboratory equipment, namely, protein sequence analysis apparatus; testing apparatus not for medical purposes, namely, research laboratory analyzers for testing blood and other bodily fluids and electronic apparatus for testing the sterility of pharmaceuticals and injectable solutions; nucleic acid sequencers used for analyzing nucleic acids in scientific research; laboratory apparatus and instruments, namely, gene analyzers for genome information; DNA chips; laboratory devices for detecting genetic sequences; laboratory chemical reactors; pipette racks for laboratory use; laboratory instrument for the detection of pathogens and toxins in a biological sample for research use | ACTIVE | — |
| 010 | Apparatus for DNA and RNA testing for medical purposes; apparatus for blood analysis; apparatus used in implementing diagnosis tests designed to detect the abnormal prion protein; probes for medical purposes; medical diagnostic apparatus for detecting genetic diseases, infectious diseases, tumors and cancer; medical diagnostic apparatus for testing DNA and RNA samples; apparatus for use in medical analysis, namely, computerized medical recording and analysis apparatus for the diagnosis and analysis of cancer, genetic diseases and microbial infectious diseases; medical apparatus and instruments, namely, apparatus for detecting tumors, cancer and genetic diseases; medical apparatus and instruments, namely, apparatus for detecting and treating tumors and cancer; medical apparatus and instruments, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; testing apparatus for medical purposes, namely, blood testing apparatus, immunochemical testing apparatus; genetic testing apparatus for medical purposes; gas chromatography apparatus for medical use | ACTIVE | — |
| 042 | Scientific laboratory services; biochemical research and analysis; medical research; research in the field of gene editing technology; research and development services in the field of antibodies; DNA screening for scientific research purposes; biological research; scientific research in the field of genetics; research on DNA sequencing technology; medical research in the field of oncology; pharmaceutical research and development; research in the field of DNA chip technology; genetic screening for scientific research purposes, namely, DNA screening for scientific research purposes; research in the field of cell engineering technology; structural and functional analysis of genomes; research and development services in the field of gene expression systems; genetic testing for scientific research purposes; medical research laboratories; software engineering services for data processing; computer programming in the medical field; computer programming; database development services | ACTIVE | — |
| 044 | Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; stem cell therapy services; DNA screening for medical purposes; genetic testing for medical purposes; genetic screening for medical purposes; disease diagnosis services, namely, providing medical testing services for disease diagnosis, performing diagnosis of diseases; medical screening; telemedicine services; medical treatment using cultured cells; medical analysis for the diagnosis and treatment of patients; providing online information about medical services; genetic testing for medical purposes; medical consultations | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by BGI SHENZHEN GROUP HOLDINGS CO., LIMITED
- Other trademarks owned by STOmics Tech Co., Ltd.
- Other trademarks owned by BGI SHENZHEN GROUP HOLDINGS CO., LIMITED
- Other trademarks owned by BGI SHENZHEN GROUP HOLDINGS CO., LIMITED
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named GO SPATIAL
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 9, 2026 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Dec 18, 2025 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Nov 27, 2025 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Nov 26, 2025 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Aug 6, 2025 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jul 26, 2025 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jul 7, 2025 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jul 7, 2025 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| May 6, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| May 6, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 18, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 18, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 12, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 24, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 30, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 29, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 29, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 23, 2024 | RFNT | REFUSAL PROCESSED BY IB | — |
| Apr 30, 2024 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Apr 30, 2024 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 19, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 18, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 30, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 16, 2024 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Feb 12, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 9, 2024 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |